Prior literature has identified EWSR1-BEND2 fusions in pancreatic neuroendocrine tumours, spinal cord ependymoma, and tongue base adenocarcinoma (Scarpa et al., 2017; Todorovic et al., 2020; Agaimy et al., 2023). Here, BEND2 is linked to spinal cord ependymoma.